Skip to main content
SpringerLink
Log in

Markers of Inflammation for Prognosis and Control of Therapeutic Success in Patients with Abdominal Sepsis — Options for Using Adjuvant Intravenous Immunoglobulins

  • Chapter
Immunological Screening and Immunotherapy in Critically ill Patients with Abdominal Infections

Abstract

Sepsis is first of all a clinical diagnosis and is based on objective clinical data according to the ACCP/SCCM-definitions from 1991, which defined sepsis as a situation with an identified or obvious infection and the criteria of systemic inflammatory response syndrome (SIRS). These criteria are temperature more than 38.4 °C or less than 36.0 °C, tachycardia of more than 90 heartbeats/minute, tachypnoea of more than 20 breaths/minute or the need for artificial ventilation and a leukocyte count of more than 12000/µl or less than 4000/µl.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alejandria MM, Lansang MA, Dans LF, Mantaring JBV (1999 and update 2000) Intravenous immunoglobulin for treating sepsis and septic shock (Cochrane-review) The Cochrane Library 3 Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentration in patients with sepsis and infection. Lancet 341: 515

    Google Scholar 

  • Becker KL, Nash DR, Silva OL, Snider RH, Moore CF (1981) Increased serum and urinary calcitonin levels in patients with pulmonary disease. Chest 79: 211

    Article  PubMed  CAS  Google Scholar 

  • Beier W (1994) Procalcitonin (ProCt) — ein innovativer Inflammationsparameter mit prognostischen Eigenschaften. Anästh Intensivmed 36: XVIII, (editorial)

    Google Scholar 

  • Bein T, Unertl K (1993) Möglichkeiten and Grenzen von Score-Systemen in der Intensivmedizin. Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 28: 476–483

    CAS  Google Scholar 

  • Bone RC (1991) The pathogenesis of sepsis. Ann Intern Med 115: 457

    PubMed  CAS  Google Scholar 

  • Brunkhorst FM, Forycki ZF, Beier W, Wagner J (1993) Discrimination of infectious and noninfectious etiologies of the adult respiratory distress syndrome (ARDS) with procalcitonin immunoreactivity. Clin Intensive Care 3 (suppl); 12

    Google Scholar 

  • Chen JY (1996) Intravenous immunoglobulin in the treatment of full term and premature newborns with sepsis. J Formos Med Assoc 24: 733–42

    Google Scholar 

  • Concato J, Shah N, Horwitz RI (2000) Randomized, controlled trials, observational studies, and the hierarchy of research design. NEJM; 342 (25): 1887–1892

    Article  PubMed  CAS  Google Scholar 

  • Döcke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W (1997) Monocyte deactivation in septic patients: restoration by IFN-y treatment. Nature Medicine 3: 678–681

    Article  PubMed  Google Scholar 

  • Garbett ND, Munro CS, Cole PJ (1989) Opsonic activity of an new intravenous immunoglobulin preparation: pentaglobin compared with sandoglobulin. Clinical Experimental Immunol, 76: 3–12

    Google Scholar 

  • Goris RJA, Boekhorst TPA, Nuytinck JKS (1985) Multiple organ failure. Arch Surg 118: 1109

    Google Scholar 

  • Grundmann R, Hornung M (1988) Immunoglobulintherapy in patients with endotoxinemia and postoperative sepsis–a prospective randomized study. Progress in clinical and biological Research 339–349

    Google Scholar 

  • Haupt W, Fritsche H, Hohenberger W, Zirngibl H (1996) Selective cytokine release induced by serum and separated plasma from septic patients. Eur J Surg 162: 769

    PubMed  CAS  Google Scholar 

  • Heney D, Lewis IJ, Evans SW, Banks R, Bailey CC, Whicher JT (1992) Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia. J Infect Dis 165: 886

    Article  PubMed  CAS  Google Scholar 

  • Heuer HO, Darius H, Lohmann HF, Meyer J, Schierenberg M, Treese N (1991) Platelet-activating factor type activity in plasma from patients with septicemia and other diseases. Lipids 26: 1381

    Article  PubMed  CAS  Google Scholar 

  • Huttemeier PC, Ritter EF, Benveniste H (1993) Calcitonin gene-related peptide mediates hypotension and tachycardia in endotoxin rats. Am J Physiol 265: 4767

    Google Scholar 

  • Joyce CD, Fiscus RR, Wang X, Dries DJ, Morris RC, Prinz RA (1990) Calcitonin related peptide levels are elevated in patients with sepsis. Surgery 108: 1097

    PubMed  CAS  Google Scholar 

  • Le Gall JR, Lemeshow S, Saulnier F (1993) A New Simplified Acute Physiology Score ( SAPS II) Based on a European/North American Multicenter Study. JAMA 270 2957–2963

    Article  PubMed  Google Scholar 

  • Marshall JC (2000) Clinical trials of mediator-directed therapy in sepsis: what have we learned? Intensive Care Med. 26: S75–83

    Article  PubMed  Google Scholar 

  • Mimos O, Benoist JF, Edouard AR, Assicot M, Bohoun C, Samii K (1998) Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 24: 185–188

    Article  Google Scholar 

  • NIH Consensus conference (1990) Intravenous immunoglobulins. Prevention and treatment of disease. JAMA 264: 3189–3193

    Article  Google Scholar 

  • Nylen ES, O’Neill WO, Jordan MH et al. (1992) Serum procalcitonin as an index of inhalation injury in burns. Horm Metab Res 24: 439

    Article  PubMed  CAS  Google Scholar 

  • Opal SM, Cross AS, Bhattacharjee AK, Visvanathan K, Zabriski JB (1999) Immunoprophylaxis against bacterial sepsis. Sepsis 3: 225–234

    Article  Google Scholar 

  • Rangel-Frausto MS, Pittet D, Costigan, RN, Hwang T, Davis, CS, Wenzel, RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS) JAMA, 273: 117–123

    Article  PubMed  CAS  Google Scholar 

  • Reist K, Hilfiker O, Stepniewski MS et al. (1996) Sepsis-Score in der operativen Intensivmedizin. Anästhesiol Intensivmed Notfallmed Schmerzther 31

    Google Scholar 

  • Reith HB, Dittrich H, Haarmann W, Smektala R, Dohle J, Kozuschek W (1996) Adjuvante Therapie der Peritonitis und ihrer septischer Verlaufsformen mit Taurolidin - eine prospektive randomisierte Untersuchung. Chir Gastroenterologie 12: 358

    Article  Google Scholar 

  • Reith HB, Mittelkötter U, Wagner R, Thiede A (2000) Procalcitonin (PCT) in patients with abdominal sepsis. Intensive Care Med. 26: S 165–169

    Google Scholar 

  • Rosman C, Grond J, Buurman WA et al. (1993) Fish oil increases the release of tumor necrosis factor and interleukin-6 and has no effect on the incidence of multiple organ failure in rats with peritonitis. Eur J Surg 159: 563

    PubMed  CAS  Google Scholar 

  • Schedel I, Dreikhausen U, Nentwig B, Hockenschnieder M, Rauthmann D, Balikcioglu S, Coldewey R, Deicher H (1991) Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective randomized clinical trial. Clinical Care Med, 10: 1104–1113

    Article  Google Scholar 

  • Werdan K (1999) Immunoglobulins in sepsis: therapeutic use of immunoglobulins. Sepsis 3: 239–245

    Article  Google Scholar 

  • Zanetti G, Calandra T (1997) Intravenous immunoglobulins and granulocyte colony-stimulating factor for the management of infection in intensive care units. Curr Opin Crit Care 3: 342–347

    Google Scholar 

Download references

Authors
  1. H. B. Reith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Mittelkötter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinikum Großhadern, Chirurgische Universtität der LMU München, Marchioninistraße 15, 81377, München, Germany

    E. Faist

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Reith, H.B., Mittelkötter, U. (2001). Markers of Inflammation for Prognosis and Control of Therapeutic Success in Patients with Abdominal Sepsis — Options for Using Adjuvant Intravenous Immunoglobulins. In: Faist, E. (eds) Immunological Screening and Immunotherapy in Critically ill Patients with Abdominal Infections. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59455-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59455-7_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-41148-2

  • Online ISBN: 978-3-642-59455-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation